I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Zinzani P. L
483
results:
Search for persons
X
Format
Online (483)
Mediatypes
Articles (Online) (200)
Bookchapter (Online) (1)
OpenAccess-fulltext (282)
Languages
english (477)
french (1)
Sorted by: Relevance
Sorted by: Year
?
1
Exposure to obinutuzumab does not affect outcomes of SARS‐C..:
Pinto, A.
;
Caltagirone, M.
;
Battista, M.
...
British Journal of Haematology. , 2024
Link:
https://doi.org/10.1111/..
?
2
MAHOGANY: A PHASE 3 TRIAL OF ZANUBRUTINIB PLUS ANTI‐CD20 VE..:
Sehn, L.
;
Sarkozy, C.
;
Song, Y.
...
Hematological Oncology. 41 (2023) S2 - p. 168-170 , 2023
Link:
https://doi.org/10.1002/..
?
3
FAVEZELIMAB PLUS PEMBROLIZUMAB IN ANTI–PD‐1–REFRACTORY CLAS..:
Armand, P.
;
Zinzani, P. L.
;
Timmerman, J.
...
Hematological Oncology. 41 (2023) S2 - p. 163-165 , 2023
Link:
https://doi.org/10.1002/..
?
4
Final safety and efficacy results of copanlisib monotherapy..:
Dreyling, M.
;
Santoro, A.
;
Mollica, L.
...
Hematological Oncology. 41 (2023) S2 - p. 560-562 , 2023
Link:
https://doi.org/10.1002/..
?
5
An open‐label phase 1/2 study of favezelimab plus pembroliz..:
Lavie, D.
;
Johnson, N.
;
Borchmann, P.
...
Hematological Oncology. 41 (2023) S2 - p. 364-366 , 2023
Link:
https://doi.org/10.1002/..
?
6
PHASE 1B OPEN‐LABEL STUDY OF LONCASTUXIMAB TESIRINE IN COMB..:
Hess, B. T.
;
Solh, M. M.
;
Gandhi, M.
...
Hematological Oncology. 41 (2023) S2 - p. 824-825 , 2023
Link:
https://doi.org/10.1002/..
?
7
A phase 2 study of zilovertamab vedotin as monotherapy or i..:
Zinzani, P. L.
;
Mayer, J.
;
Benjamini, O.
...
Hematological Oncology. 41 (2023) S2 - p. 564-565 , 2023
Link:
https://doi.org/10.1002/..
?
8
AFM13 IN PATIENTS WITH CD30 POSITIVE RELAPSED OR REFRACTORY..:
Kim, W. S.
;
Shortt, J.
;
Zinzani, P. L.
...
Hematological Oncology. 41 (2023) S2 - p. 195-196 , 2023
Link:
https://doi.org/10.1002/..
?
9
EFFICACY AND SAFETY OF MOLTO, A MULTICENTER, OPEN LABEL, PH..:
Frustaci, A. M.
;
Montillo, M.
;
Rossi, D.
...
Hematological Oncology. 41 (2023) S2 - p. 62-63 , 2023
Link:
https://doi.org/10.1002/..
?
10
GLOFITAMAB PLUS POLATUZUMAB VEDOTIN DEMONSTRATES DURABLE RE..:
Hutchings, M.
;
Avigdor, A.
;
Sureda, A.
...
Hematological Oncology. 41 (2023) S2 - p. 138-140 , 2023
Link:
https://doi.org/10.1002/..
?
11
CART‐SIE REAL LIFE STUDY: PRIMARY MEDIASTINAL B‐CELL LYMPHO..:
Chiappella, A.
;
Dodero, A.
;
Guidetti, A.
...
Hematological Oncology. 41 (2023) S2 - p. 198-199 , 2023
Link:
https://doi.org/10.1002/..
?
12
PILOT PHASE II STUDY OF SELINEXOR IN COMBINATION WITH IFOSF..:
Chiappella, A.
;
Dodero, A.
;
Carniti, C.
...
Hematological Oncology. 41 (2023) S2 - p. 845-846 , 2023
Link:
https://doi.org/10.1002/..
?
13
BEGEV as salvage regimen in first setting for relapsed/refr..:
Carella, M.
;
Argnani, L.
;
Coppola, P. E.
...
Hematological Oncology. 41 (2023) S2 - p. 360-361 , 2023
Link:
https://doi.org/10.1002/..
?
14
Role of autologous stem cell transplantation or salvage che..:
Pellegrini, C.
;
Casadei, B.
;
Sutto, E.
...
Hematological Oncology. 41 (2023) S2 - p. 368-369 , 2023
Link:
https://doi.org/10.1002/..
?
15
The treatment of Burkitt lymphoma with the Berlin‐Frankfurt..:
Broccoli, A.
;
Argnani, L.
;
Gugliotta, G.
...
Hematological Oncology. 41 (2023) S2 - p. 427-427 , 2023
Link:
https://doi.org/10.1002/..
1-15